Summit Therapeutics Inc. Diluted Earnings Loss Per Share
Summit Therapeutics Inc. (SMMT) reported Diluted Earnings Loss Per Share of -0.01 GBP/shares for the 3-month period ending 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShare · last filed 2020-06-02
- Summit Therapeutics Inc. diluted earnings loss per share for the quarter ending 2020-03-31 was -0.01 GBP/shares.
- Summit Therapeutics Inc. diluted earnings loss per share for the quarter ending 2019-10-31 was -0.04 GBP/shares.
- Summit Therapeutics Inc. diluted earnings loss per share for the quarter ending 2019-07-31 was -0.03 GBP/shares, a 109.38% decline year-over-year.
- Summit Therapeutics Inc. diluted earnings loss per share for the quarter ending 2019-03-31 was -0.03 GBP/shares.
| Period end | Diluted Earnings Loss Per Share 3 month | Diluted Earnings Loss Per Share 6 month | Diluted Earnings Loss Per Share 9 month | Diluted Earnings Loss Per Share 11 month | Diluted Earnings Loss Per Share 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | -0.01 GBP/shares 6-K · filed 2020-06-02 | ||||
| 2019-12-31 | -0.13 GBP/shares 20-F · filed 2020-04-30 | ||||
| 2019-10-31 | -0.04 GBP/shares 6-K · filed 2019-12-17 | -0.10 GBP/shares 6-K · filed 2019-12-17 | |||
| 2019-07-31 | -0.03 GBP/shares 6-K · filed 2019-10-11 | -0.06 GBP/shares 6-K · filed 2019-10-11 | |||
| 2019-03-31 | -0.03 GBP/shares 6-K · filed 2020-06-02 | ||||
| 2019-01-31 | 0.09 GBP/shares 20-F · filed 2020-04-30 | ||||
| 2018-10-31 | -0.10 GBP/shares 6-K · filed 2019-12-17 | 0.16 GBP/shares 6-K · filed 2019-12-17 | |||
| 2018-07-31 | 0.32 GBP/shares 6-K · filed 2019-10-11 | 0.26 GBP/shares 6-K · filed 2019-10-11 | |||
| 2018-01-31 | -0.31 GBP/shares 20-F · filed 2020-04-30 | ||||
| 2017-10-31 | -0.01 GBP/shares 6-K · filed 2018-12-11 | -0.14 GBP/shares 6-K · filed 2018-12-11 | |||
| 2017-07-31 | 0.00 GBP/shares 6-K · filed 2018-09-20 | 0.00 GBP/shares 6-K · filed 2018-09-20 | |||
| 2017-01-31 | -0.35 GBP/shares 20-F · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |